542 related articles for article (PubMed ID: 16088948)
1. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors.
Xu W; Zhu JP; Angulo JA
Synapse; 2005 Nov; 58(2):110-21. PubMed ID: 16088948
[TBL] [Abstract][Full Text] [Related]
2. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Brain Res; 2005 Jul; 1049(2):171-81. PubMed ID: 16043139
[TBL] [Abstract][Full Text] [Related]
3. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.
Angulo JA; Angulo N; Yu J
Ann N Y Acad Sci; 2004 Oct; 1025():171-80. PubMed ID: 15542715
[TBL] [Abstract][Full Text] [Related]
4. Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.
Yu J; Wang J; Cadet JL; Angulo JA
Brain Res; 2004 May; 1007(1-2):124-31. PubMed ID: 15064143
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.
Zhu JP; Xu W; Angulo JA
Neuroscience; 2006 Jun; 140(2):607-22. PubMed ID: 16650608
[TBL] [Abstract][Full Text] [Related]
6. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons.
Centonze D; Grande C; Usiello A; Gubellini P; Erbs E; Martin AB; Pisani A; Tognazzi N; Bernardi G; Moratalla R; Borrelli E; Calabresi P
J Neurosci; 2003 Jul; 23(15):6245-54. PubMed ID: 12867509
[TBL] [Abstract][Full Text] [Related]
7. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity.
Thomas DM; Francescutti-Verbeem DM; Kuhn DM
J Neurochem; 2008 May; 105(3):605-16. PubMed ID: 18088364
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
9. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain.
Liu Q; Hazan A; Grinman E; Angulo JA
Brain Res; 2017 Mar; 1659():148-155. PubMed ID: 28130052
[TBL] [Abstract][Full Text] [Related]
11. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine.
Wang JQ; McGinty JF
Synapse; 1996 Feb; 22(2):114-22. PubMed ID: 8787127
[TBL] [Abstract][Full Text] [Related]
12. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis.
Guillot TS; Shepherd KR; Richardson JR; Wang MZ; Li Y; Emson PC; Miller GW
J Neurochem; 2008 Sep; 106(5):2205-17. PubMed ID: 18643795
[TBL] [Abstract][Full Text] [Related]
13. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
Achat-Mendes C; Anderson KL; Itzhak Y
Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
[TBL] [Abstract][Full Text] [Related]
14. Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain.
Yu J; Cadet JL; Angulo JA
J Neurochem; 2002 Nov; 83(3):613-22. PubMed ID: 12390523
[TBL] [Abstract][Full Text] [Related]
15. Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation.
Wersinger C; Chen J; Sidhu A
Mol Cell Neurosci; 2004 Jan; 25(1):124-37. PubMed ID: 14962746
[TBL] [Abstract][Full Text] [Related]
16. Effects of toxic doses of methamphetamine (METH) on dopamine D1 receptors in the mouse brain.
Cadet JL; Ladenheim B; Hirata H
Brain Res; 1998 Mar; 786(1-2):240-2. PubMed ID: 9555035
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.
Krasnova IN; Hodges AB; Ladenheim B; Rhoades R; Phillip CG; Cesena A; Ivanova E; Hohmann CF; Cadet JL
Neurosci Res; 2009 Oct; 65(2):160-5. PubMed ID: 19559060
[TBL] [Abstract][Full Text] [Related]
18. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
[TBL] [Abstract][Full Text] [Related]
19. Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice.
Zhu JP; Xu W; Angulo JA
Ann N Y Acad Sci; 2006 Aug; 1074():135-48. PubMed ID: 17105911
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
